Guanmei Wen

1.0k citations
18 papers · 730 indexed · h-index 13
Topics
Protease and Inhibitor Mechanisms (4 papers)Cell Adhesion Molecules Research (4 papers)MicroRNA in disease regulation (3 papers)

In The Last Decade

Guanmei Wen

18 papers receiving 727 citations

Peers

Guanmei Wen
Comparison fields: 5 of 86
  • Molecular Biology 389
  • Cancer Research 274
  • Immunology 140
  • Oncology 78
  • Toxicology 78
Replace Bo-Jeong Pyun with:
Bo-Jeong Pyun South Korea
Rebekah L. Waikel United States
Elisa Lorenzo Italy
Yongchun Yu China
Xinzheng Dai China
Ledong Wan China
Yongzhong Yao China
Yonggang Wang China
Dongxian Guan China
Wuguo Li China
Guanmei Wen relative to Bo-Jeong Pyun South Korea Bo-Jeong Pyun's profile →
Citations per field
00.5×4.9×
Bo-Jeong Pyun · 1×
Citations per year

Countries citing papers authored by Guanmei Wen

Since Specialization
Citations

This map shows the geographic impact of Guanmei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanmei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanmei Wen more than expected).

Fields of papers citing papers by Guanmei Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanmei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanmei Wen. The network helps show where Guanmei Wen may publish in the future.

Co-authorship network of co-authors of Guanmei Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Guanmei Wen. A scholar is included among the top collaborators of Guanmei Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanmei Wen. Guanmei Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 3
2 54
3 11
4 3
5 31
6 44
7 43
8 69
9 44
10 54
11 1
12 72
13 32
14 53
15 40
16 136
17 38
18
Studies on differentiation potential of human bone marrow mesenchymal stem cells into hematopoietic cells in vivo
2

About Guanmei Wen

Guanmei Wen is a scholar working on Immunology and Allergy, Cancer Research and Toxicology, having authored 18 papers that have together received 730 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (4 papers), Cell Adhesion Molecules Research (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Toxicology (78 citations), Cancer Research (274 citations) and Immunology and Allergy (44 citations). Guanmei Wen has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Qingzhong Xiao, Shu Ye, Qishan Chen, Jinbao Liu, Le Anh Luong, Li Zhang, Cheng Zhang, Changcun Fang, Xiangyuan Pu and Leyi Yao. Their work appears in journals such as Journal of Biological Chemistry, Circulation Research and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026